Australia markets closed

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9000+0.1300 (+4.69%)
At close: 04:00PM EDT
2.9000 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-19,260
-19,381
-13,676
-13,592
-12,292
-
Depreciation & amortisation
31
30
25
24
21
-
Stock-based compensation
1,749
1,683
1,502
1,558
1,843
-
Change in working capital
-1,536
93
585
-461
1,195
-
Accounts receivable
-
-
-
-
-
-43
Accounts payable
-1,064
192
225
-590
917
-
Other working capital
-20,318
-18,752
-11,592
-12,274
-9,232
-
Other non-cash items
71
70
64
58
52
-
Net cash provided by operating activities
-20,292
-18,728
-11,511
-12,252
-9,185
-
Cash flows from investing activities
Investments in property, plant and equipment
-26
-24
-81
-22
-47
-
Purchases of investments
-69,369
-69,410
-45,684
-69,813
-39,746
-
Sales/maturities of investments
52,795
51,135
57,303
49,296
23,643
-
Net cash used for investing activities
-16,600
-18,299
11,538
-20,537
-16,134
-
Cash flows from financing activities
Debt repayment
-6
-6
-6
-6
-5
-
Common stock issued
-
36,848
0
29,849
28,805
-
Net cash used provided by (used for) financing activities
36,842
36,842
-6
30,087
28,845
-
Net change in cash
-50
-185
21
-2,702
3,526
-
Cash at beginning of period
2,147
4,728
4,707
7,409
3,883
-
Cash at end of period
2,097
4,543
4,728
4,707
7,409
-
Free cash flow
Operating cash flow
-20,292
-18,728
-11,511
-12,252
-9,185
-
Capital expenditure
-26
-24
-81
-22
-47
-
Free cash flow
-20,318
-18,752
-11,592
-12,274
-9,232
-